Creatine phosphokinase elevation exacerbated by levetiracetam therapy
A 19-year-old muscular male with a history of epilepsy presented following two convulsive events. Levetiracetam (LEV) was given as an additional therapy, resulting in a marked boost in creatine phosphokinase (CPK) that could not easily be explained by renal dysfunction or rhabdomyolysis alone. Levet...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2014-01-01
|
| Serija: | Epilepsy and Behavior Case Reports |
| Teme: | |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S2213323214000504 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|